Sonnet BioTherapeutics Merges to Launch Hyperliquid Strategies

  • TL;DR Sonnet will merge its business with Rorschach I LLC to form Hyperliquid Strategies Inc., a publicly traded company that will manage one of the largest public HYPE token reserves. The deal includes $305 million in cash and 12.6 million HYPE tokens, backed by investors such as Paradigm, Pantera, and Galaxy Digital.